Prospective analysis of adrenal function in patients with acute exacerbations of COPD: The reduction in the use of corticosteroids in exacerbated COPD (REDUCE) trial

European Journal of Endocrinology

Volumn 173, Issue 1, 2015, Pages 19-27

  Schuetz, Philipp ^a   DLeuppi, Jörg ^b   Bingisser, Roland ^c   Bodmer, Michael ^c   Briel, Matthias ^d,l   Drescher, Tilman ^c   Duerring, Ursula ^c   Henzen, Christoph ^e   Leibbrandt, Yolanda ^f   Maier, Sabrina ^b   Miedinger, David ^b   Mueller, Beat ^a   Scherr, Andreas ^c   Schindler, Christian ^g   Stoeckli, Rolf ^c   Viatte, Sebastien ^f,h   Von Garnier, Christophe ⁱ   Tamm, Michael ^c   Rutishauser, Jonas ^j,k  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b Kantonsspital Liestal   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e LUZERNER KANTONSSPITAL   (Switzerland)

^f Hospital Center of Biel   (Switzerland)

^g UNIVERSITY OF BASEL   (Switzerland)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁱ UNIVERSITY OF BERN   (Switzerland)

^j Medical University Clinic   (Switzerland)

^k UNIVERSITY OF BASEL   (Switzerland)

^l MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; HYDROCORTISONE; PLACEBO; PREDNISONE; TIOTROPIUM BROMIDE; CORTICOSTEROID; CORTICOTROPIN;

ADRENAL CORTEX INSUFFICIENCY; ADRENAL FUNCTION; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; CORTICOTROPIN TEST; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; ENERGY; ENERGY LOSS; FATIGUE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MYALGIA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK; TREATMENT DURATION; ADRENAL GLAND; ADRENAL INSUFFICIENCY; CLINICAL TRIAL; DEFICIENCY; DIAGNOSTIC USE; DRUG EFFECTS; ENDOCRINE FUNCTION TEST; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

ADRENAL CORTEX FUNCTION TESTS; ADRENAL CORTEX HORMONES; ADRENAL GLANDS; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PREDNISONE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84935097076     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0182     Document Type: Article

References (23)

1. Global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD), updated January 2015. www.goldcopd.org.
2. Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. Journal of the American Medical Association 2013 309 2223-2231. (doi:10.1001/jama.2013.5023)
3. Arlt W & Allolio B. Adrenal insufficiency. Lancet 2003 361 1881-1893. (doi:10.1016/S0140-6736(03)13492-7)
4. Sacre K, Dehoux M, Chauveheid MP, Chauchard M, Lidove O, Roussel R & Papo T. Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: an observational study. Journal of Clinical Endocrinology and Metabolism 2013 98 3199-3205. (doi:10.1210/jc.2013-1394)
5. Schlaghecke R, Kornely E, Santen RT & Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. New England Journal of Medicine 1992 326 226-230. (doi:10.1056/NEJM199201233260403)
6. Henzen C, Suter A, Lerch E, Urbinelli R, Schorno XH & Briner VA. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000 355 542-545. (doi:10.1016/S0140-6736(99)06290-X)
7. Jones SL, Trainer PJ, Perry L, Wass JA, Bessser GM & Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clinical Endocrinology 1994 41 123-128. (doi:10.1111/j.1365-2265.1994.tb03793.x)
8. Dickstein G, Shechner C, Nicholson WE, Rosner I, Shen-Orr Z, Adawi F & Lahav M. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. Journal of Clinical Endocrinology and Metabolism 1991 72 773-778. (doi:10.1210/jcem-72-4-773)
9. Thaler LM & Blevins LS Jr. The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 2726-2729.
10. Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gonc EN et al. Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: a metaanalysis. Journal of Clinical Endocrinology and Metabolism 2008 93 4245-4253. (doi:10.1210/jc.2008-0710)
11. Mayenknecht J, Diederich S, Bahr V, Plockinger U & Oelkers W. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. Journal of Clinical Endocrinology and Metabolism 1998 83 1558-1562. (doi:10.1210/jcem.83.5.4831)
12. Dorin RI, Qualls CR & Crapo LM. Diagnosis of adrenal insufficiency. Annals of Internal Medicine 2003 139 194-204. (doi:10.7326/0003-4819-139-3-200308050-00017)
13. Stewart PM & Clark PM. The low-dose corticotropin-stimulation test revisited: the less, the better? Nature Clinical Practice. Endocrinology &Metabolism 2009 5 68-69. (doi:10.1038/ncpendmet1038)
14. Oelkers W. M. Pura et al. (Lubochna and Prague) with the title: "The low dose (1 microg) cosyntropin test (LDT) for primary adrenocortical insufficiency: defining the normal cortisol response and report on first patients with Addison disease confirmed with LDT" (ECED; 118: 151-157). Experimental and Clinical Endocrinology & Diabetes 2010 118 339-340. (doi:10.1055/s-0030-1253438)
15. Widmer IE, Puder JJ, König C, Pargger H, Zerkowski HR, Girard J &Müller B. Cortisol response in relation to the severity of stress and illness. Journal of Clinical Endocrinology and Metabolism 2005 90 4579-4586. (doi:10.1210/jc.2005-0354)
16. Richter B, Neises G & Clar C. Glucocorticoid withdrawal schemes in chronic medical disorders. A systematic review. Endocrinology and Metabolism Clinics of North America 2002 31 751-778. (doi:10.1016/S0889-8529(02)00008-7)
17. Schuetz P, Leuppi JD, Tamm M, Briel M, Bingisser R, Dürring U, Müller B, Schindler C, Viatte S & Rutishauser J. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease - the "REDUCE" trial. Swiss Medical Weekly 2010 140 w13109.
18. Arlt W, Rosenthal C, Hahner S & Allolio B. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs timed serum cortisol measurements. Clinical Endocrinology 2006 64 384-389.
19. Schuetz P, Christ-Crain M, Schild U, Suess E, Facompre M, Baty F, Nusbaumer C, Brutsche M & Muller B. Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease. BMC Pulmonary Medicine 2008 8 1. (doi:10.1186/1471-2466-8-1)
20. Hochberg Z, Pacak K & Chrousos GP. Endocrine withdrawal syndromes. Endocrine Reviews 2003 24 523-538. (doi:10.1210/er.2001-0014)
21. Kountz DS & Clark CL. Safely withdrawing patients from chronic glucocorticoid therapy. American Family Physician 1997 55 521-525, 529-530.
22. Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq PE, Vanwijngaerden Y-M, Spriet I, Wouters PJ, Vander Perre S et al. Reduced cortisol metabolism during critical illness. New England Journal of Medicine 2013 368 1477-1488. (doi:10.1056/NEJMoa1214969)
23. Hatton MQ, Vathenen AS, Allen MJ, Davies S & Cooke NJ. A comparison of 'abruptly stopping' with 'tailing off' oral corticosteroids in acute asthma. Respiratory Medicine 1995 89 101-104. (doi:10.1016/0954-6111(95)90191-4)